Endpoints News

FDA approves Novo Nordisk’s once-weekly insulin

Published

2 weeks ago

on

The FDA finally greenlit Novo Nordisk’s once-weekly insulin for type 2 diabetes, making it the first US-approved longer-acting alternative to daily basal treatment for this indication.

The Thursday approval of the …

Related Topics:

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version